Clinical Trial Update: Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia [Phase 3]

View source ↗

Summary

Phase 3 study investigating the optimal dose of remifentanil during MRI of the heart under general anesthesia in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Diseases

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Alder Hey Children's NHS Foundation Trust | Conditions: Children, Heart Diseases | Phase 3 | Status: UNKNOWN